Apple v Masimo

Apple smartwatches could face an import ban after a U.S. judge ruled that the company infringed on one of Masimo’s pulse oximeter patents.

Apple is planning to stop selling some versions of the Apple Watch in the United States as soon as this week to get ahead of what could be one of the most momentous patent disputes in years.

US president Joe Biden’s administration on Tuesday opted not to veto a government tribunal’s ruling to ban imports of Apple Watches.

Apple filed an emergency motion with a U.S. appeals court to pause a ban on importing and selling some of its Apple Watch models.

Apple will be able to sell the latest Apple Watches after an import ban was temporarily stopped by a U.S. appeals court on Wednesday.

Apple has started resuming sales of its Apple Watch Series 9 and Ultra 2 in the country.

Apple is planning to remove its blood-oxygen feature from the Apple Watch Series 9 and Apple Watch Ultra 2, to circumvent a US ban of the devices.

From Jan. 18, Apple will again be banned from selling Apple Watch Series 9 and Ultra 2 devices in the US due to its ongoing patent infringement case with Masimo.

Apple has released iOS 18.6.1 for U.S. iPhones only, bringing a Blood Oxygen monitoring update.

Apple has released watchOS 11.6.1 in tandem with iOS 18.6.1 bringing a Blood Oxygen monitoring update in the United States.

Masimo has filed a lawsuit against U.S. Customs and Border Protection (CBP) over the reactivation of the Apple Watch’s Blood Oxygen feature.

Masimo recently filed a lawsuit against U.S. Customs and Border Protection, accusing the agency of improperly allowing Apple to resume selling Apple Watches with the Blood Oxygen feature activated.